Literature DB >> 23229891

PET/CT-guided interventions: personnel radiation dose.

E Ronan Ryan1, Raymond Thornton, Constantinos T Sofocleous, Joseph P Erinjeri, Meier Hsu, Brian Quinn, Lawrence T Dauer, Stephen B Solomon.   

Abstract

PURPOSE: To quantify radiation exposure to the primary operator and staff during PET/CT-guided interventional procedures.
METHODS: In this prospective study, 12 patients underwent PET/CT-guided interventions over a 6 month period. Radiation exposure was measured for the primary operator, the radiology technologist, and the nurse anesthetist by means of optically stimulated luminescence dosimeters. Radiation exposure was correlated with the procedure time and the use of in-room image guidance (CT fluoroscopy or ultrasound).
RESULTS: The median effective dose was 0.02 (range 0-0.13) mSv for the primary operator, 0.01 (range 0-0.05) mSv for the nurse anesthetist, and 0.02 (range 0-0.05) mSv for the radiology technologist. The median extremity dose equivalent for the operator was 0.05 (range 0-0.62) mSv. Radiation exposure correlated with procedure duration and with the use of in-room image guidance. The median operator effective dose for the procedure was 0.015 mSv when conventional biopsy mode CT was used, compared to 0.06 mSv for in-room image guidance, although this did not achieve statistical significance as a result of the small sample size (p = 0.06).
CONCLUSION: The operator dose from PET/CT-guided procedures is not significantly different than typical doses from fluoroscopically guided procedures. The major determinant of radiation exposure to the operator from PET/CT-guided interventional procedures is time spent in close proximity to the patient.

Entities:  

Mesh:

Year:  2012        PMID: 23229891      PMCID: PMC9382846          DOI: 10.1007/s00270-012-0515-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.797


  16 in total

1.  Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.

Authors:  Helmut Schoellnast; Steven M Larson; Sadek A Nehmeh; Jorge A Carrasquillo; Raymond H Thornton; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2010-05-28       Impact factor: 2.740

2.  Optimization of urinary FDG excretion during PET imaging.

Authors:  J K Moran; H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1999-08       Impact factor: 10.057

3.  PET/CT-guided percutaneous biopsy of abdominal masses: initial experience.

Authors:  Servet Tatli; Victor H Gerbaudo; Christina M Feeley; Paul B Shyn; Kemal Tuncali; Stuart G Silverman
Journal:  J Vasc Interv Radiol       Date:  2011-03-02       Impact factor: 3.464

4.  Clinical utility of real-time fusion guidance for biopsy and ablation.

Authors:  Jochen Krücker; Sheng Xu; Aradhana Venkatesan; Julia K Locklin; Hayet Amalou; Neil Glossop; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2011-02-26       Impact factor: 3.464

5.  CT-guided treatment of ultrasonically invisible hepatocellular carcinoma.

Authors:  M Sato; Y Watanabe; K Tokui; K Kawachi; S Sugata; J Ikezoe
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

6.  Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

Authors: 
Journal:  Ann ICRP       Date:  1998

7.  Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.

Authors:  Peter N Burns; Stephanie R Wilson
Journal:  Radiology       Date:  2006-11-07       Impact factor: 11.105

8.  AAPM Task Group 108: PET and PET/CT shielding requirements.

Authors:  Mark T Madsen; Jon A Anderson; James R Halama; Jeff Kleck; Douglas J Simpkin; John R Votaw; Richard E Wendt; Lawrence E Williams; Michael V Yester
Journal:  Med Phys       Date:  2006-01       Impact factor: 4.071

9.  Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients.

Authors:  T P Chambers; R L Baron; R M Lush; G D Dodd; W J Miller
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

10.  Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

Authors:  Bingsheng Huang; Martin Wai-Ming Law; Pek-Lan Khong
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

View more
  11 in total

Review 1.  Navigational Tools for Interventional Radiology and Interventional Oncology Applications.

Authors:  Monzer A Chehab; Waleed Brinjikji; Alexander Copelan; Aradhana M Venkatesan
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.

Authors:  Louise M Fanchon; Snjezana Dogan; Andre L Moreira; Sean A Carlin; C Ross Schmidtlein; Ellen Yorke; Aditya P Apte; Irene A Burger; Jeremy C Durack; Joseph P Erinjeri; Majid Maybody; Heiko Schöder; Robert H Siegelbaum; Constantinos T Sofocleous; Joseph O Deasy; Stephen B Solomon; John L Humm; Assen S Kirov
Journal:  J Nucl Med       Date:  2015-02-26       Impact factor: 10.057

Review 3.  Interventional Molecular Imaging.

Authors:  Stephen B Solomon; Francois Cornelis
Journal:  J Nucl Med       Date:  2016-02-11       Impact factor: 10.057

4.  Real-time intraprocedural 18F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre.

Authors:  Renjith Kalathoorakathu Radhakrishnan; Bhagwant Rai Mittal; Arun Kumar Reddy Gorla; Rajender Kumar Basher; Ashwani Sood; Amanjit Bal; Naveen Kalra; Niranjan Khandelwal; Navneet Singh; Digambar Behera
Journal:  Br J Radiol       Date:  2017-10-27       Impact factor: 3.039

5.  PET/CT-Guided Interventions in Oncology Patients: A Nursing Perspective.

Authors:  Julia S Taylor; Leah Keller; Majid Maybody
Journal:  J Radiol Nurs       Date:  2017-05-20

6.  Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities.

Authors:  F Cornelis; M Silk; H Schoder; H Takaki; J C Durack; J P Erinjeri; C T Sofocleous; R H Siegelbaum; M Maybody; S B Solomon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-09       Impact factor: 9.236

7.  Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injection.

Authors:  Assen S Kirov; Louise M Fanchon; Daniel Seiter; Christian Czmielewski; James Russell; Snjezana Dogan; Sean Carlin; Katja Pinker-Domenig; Ellen Yorke; C Ross Schmidtlein; Vitaly Boyko; Sho Fujisawa; Katia Manova-Todorova; Pat Zanzonico; Lawrence Dauer; Joseph O Deasy; John L Humm; Stephen Solomon
Journal:  Med Phys       Date:  2018-03-23       Impact factor: 4.071

8.  Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.

Authors:  E Ronan Ryan; Constantinos T Sofocleous; Heiko Schöder; Jorge A Carrasquillo; Sadek Nehmeh; Steven M Larson; Raymond Thornton; Robert H Siegelbaum; Joseph P Erinjeri; Stephen B Solomon
Journal:  Radiology       Date:  2013-04-05       Impact factor: 11.105

9.  Initial Experience of Utilizing Real-Time Intra-Procedural PET/CT Biopsy.

Authors:  Carina Mari Aparici; Rizwan Aslam; Aung Zaw Win
Journal:  J Clin Imaging Sci       Date:  2014-09-29

10.  Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided Biopsies.

Authors:  Tamanna Lakhanpal; Bhagwant Rai Mittal; Rajender Kumar; Ankit Watts; Nivedita Rana; Harmandeep Singh
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.